ROS1 gene mutations can occur in a variety of tumors, including NSCLC (1%–2%),44 gliomas (6%–7%),45 and cholangiocarcinomas (1.1%),46 among which ROS1 fusion NSCLC is the most common. Here, ROS1 is linked to cholangiocarcinoma.